|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61P 3/10 |
| (11) | Number of the document | 3534936 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17801363.7 |
| Date of filing the European patent application | 2017-11-01 | |
| (97) | Date of publication of the European application | 2019-09-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/077949 |
| Date | 2017-11-01 |
| (87) | Number | WO 2018/083111 |
| Date | 2018-05-11 |
| (30) | Number | Date | Country code |
| 201662415717 P | 2016-11-01 | US | |
| 17150037 | 2017-01-02 | EP | |
| 17169019 | 2017-05-02 | EP | |
| 17177289 | 2017-06-22 | EP | |
| 17198041 | 2017-10-24 | EP |
| (72) |
CHAPLIN, Jay, DK
WIJARANAKULA, Michael, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | TOLEROGENIC DNA VACCINE |
| TOLEROGENIC DNA VACCINE |